Impinj Announces Fourth Quarter and Full Year 2017 Financial Results
Feb 15, 2018 21:15 pm UTC| Business
SEATTLE, Feb. 15, 2018 -- Impinj, Inc. (NASDAQ:PI), a leading provider and pioneer of RAIN RFID solutions for identifying, locating and authenticating everyday items, today announced its financial results for the fourth...
H&R Block to Release Fiscal Third Quarter Results March 6, 2018
Feb 15, 2018 21:15 pm UTC| Business
KANSAS CITY, Mo., Feb. 15, 2018 -- HR Block, Inc. (NYSE:HRB) will report fiscal 2018 third quarter results on Tuesday, March 6, 2018 after the New York Stock Exchange market close. At that time, a copy of the press...
Targa Resources Partners LP Announces Monthly Distribution on Preferred Units
Feb 15, 2018 21:15 pm UTC| Business
HOUSTON, Feb. 15, 2018 -- Targa Resources Partners LP (“Targa Resources Partners” or the “Partnership”) (NYSE: NGLS PR A) announced its monthly distribution on the Partnership’s 9.00% Series A Fixed-to-Floating Rate...
SPX Reports Fourth Quarter and Full-Year 2017 Results
Feb 15, 2018 21:15 pm UTC| Business
Q4 and Full-Year 2017 GAAP EPS of $1.35 and $1.91Q4 and Full-Year 2017 Adjusted EPS* of $0.60 and $1.78Introducing 2018 Full-Year Adjusted EPS* Guidance Range of $2.03-$2.18Increasing Capital Availability through 2020 by...
LogMeIn Announces Fourth Quarter and Fiscal Year 2017 Results
Feb 15, 2018 21:08 pm UTC| Business
BOSTON, Feb. 15, 2018 -- LogMeIn, Inc. (NASDAQ:LOGM), a leading provider of cloud-based connectivity, today announced its results for the fourth quarter and fiscal year ended December 31, 2017. Fourth quarter...
Feb 15, 2018 21:06 pm UTC| Business
HOUSTON, Feb. 15, 2018 -- Kayne Anderson Energy Total Return Fund (KYE) to merge with and into Kayne Anderson Midstream/Energy Fund (KMF) in a non-taxable transaction (the “Merger”)Exchange ratio to be based on...
Feb 15, 2018 21:06 pm UTC| Business
CAMBRIDGE, Mass., Feb. 15, 2018 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious cardiometabolic...